Effect of Baseline Glycemic Level on Long-Term Cardiovascular Outcomes After Coronary Revascularization Therapy in Patients With Type 2 Diabetes Mellitus Treated With Hypoglycemic Agents

American Journal of Cardiology

Volumn 105, Issue 7, 2010, Pages 960-966

  Ehara, Natsuhiko ^a   Morimoto, Takeshi ^b   Furukawa, Yutaka ^a   Shizuta, Satoshi ^c   Taniguchi, Ryoji ^d   Nakagawa, Yoshihisa ^e   Hoshino, Kozo ^f   Saito, Naritatsu ^c   Doi, Takahiro ^c   Haruna, Yoshisumi ^g   Ozasa, Neiko ^c   Imai, Yukiko ^h   Teramukai, Satoshi ^h   Fukushima, Masanori ^h   Kita, Toru ^a   Kimura, Takeshi ^c  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

^d HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^e TENRI HOSPITAL   (Japan)

^f Nagai Hospital   (Japan)

^g Hirakata Kohsai Hospital   (Japan)

^h Translational Research Informatics Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN II ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NATEGLINIDE; SULFONYLUREA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIET; DISEASE REGISTRY; ELECTIVE SURGERY; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; TREATMENT OUTCOME;

AGED; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MYOCARDIAL REVASCULARIZATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 77949571555     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.11.024     Document Type: Article

References (20)

1. Berry C., Tardif J.C., and Bourassa M.G. Coronary heart disease in patients with diabetes. Part II: recent advances in coronary revascularization. J Am Coll Cardiol 49 (2007) 643-656
2. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., Hadden D., Turner R.C., and Holman R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
3. American Diabetes Association. Standards of medical care in diabetes-2008. Diabetes Care 31 Suppl 1 (2008) S12-S54
4. Gerstein H.C., Miller M.E., Byington R.P., Goff Jr. D.C., Bigger J.T., Buse J.B., Cushman W.C., Genuth S., Ismail-Beigi F., Grimm Jr. R.H., Probstfield J.L., Simons-Morton D.G., and Friedewald W.T. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
5. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., Hayward R., Warren S.R., Goldman S., McCarren M., Vitek M.E., Henderson W.G., and Huang G.D. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139
6. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., Hamet P., Harrap S., Heller S., Liu L., Mancia G., Mogensen C.E., Pan C., Poulter N., Rodgers A., Williams B., Bompoint S., de Galan B.E., Joshi R., and Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
7. Ray K.K., Seshasai S.R., Wijesuriya S., Sivakumaran R., Nethercott S., Preiss D., Erqou S., and Sattar N. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
8. Turnbull F.M., Abraira C., Anderson R.J., Byington R.P., Chalmers J.P., Duckworth W.C., Evans G.W., Gerstein H.C., Holman R.R., Moritz T.E., Neal B.C., Ninomiya T., Patel A.A., Paul S.K., Travert F., and Woodward M. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 52 (2009) 2288-2298
9. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-Year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008) 1565-1576
10. Kimura T., Morimoto T., Furukawa Y., Nakagawa Y., Shizuta S., Ehara N., Taniguchi R., Doi T., Nishiyama K., Ozasa N., Saito N., Hoshino K., Mitsuoka H., Abe M., Toma M., Tamura T., Haruna Y., Imai Y., Teramukai S., Fukushima M., and Kita T. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era. Circulation 118 (2008) S199-S209
11. Jiao Y., Okumiya T., Saibara T., Park K., and Sasaki M. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care 21 (1998) 1732-1735
12. Peacock T.P., Shihabi Z.K., Bleyer A.J., Dolbare E.L., Byers J.R., Knovich M.A., Calles-Escandon J., Russell G.B., and Freedman B.I. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 73 (2008) 1062-1068
13. Japanese Diabetes Society. Treatment Guide for Diabetes 2007 (2007), Bunkodo, Tokyo 16-18
14. Serruys P.W., Ong A.T., van Herwerden L.A., Sousa J.E., Jatene A., Bonnier J.J., Schonberger J.P., Buller N., Bonser R., Disco C., Backx B., Hugenholtz P.G., Firth B.G., and Unger F. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol 46 (2005) 575-581
15. Collet D. Modelling Survival Data in Medical Research. 2nd ed. (2003), Chapman & Hall/CRC, Boca Raton 142-144
16. Hasdai D., Rizza R.A., Grill D.E., Scott C.G., Garratt K.N., and Holmes Jr. D.R. Glycemic control and outcome of diabetic patients after successful percutaneous coronary revascularization. Am Heart J 141 (2001) 117-123
17. Corpus R.A., George P.B., House J.A., Dixon S.R., Ajluni S.C., Devlin W.H., Timmis G.C., Balasubramaniam M., and O'Neill W.W. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. J Am Coll Cardiol 43 (2004) 8-14
18. Halkos M.E., Lattouf O.M., Puskas J.D., Kilgo P., Cooper W.A., Morris C.D., Guyton R.A., and Thourani V.H. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 86 (2008) 1431-1437
19. Furukawa Y., Taniguchi R., Ehara N., Ozasa N., Haruna Y., Saito N., Doi T., Hoshino K., Shizuta S., Morimoto T., Imai Y., Teramukai S., Fukushima M., Kita T., and Kimura T. Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease. Circ J 72 (2008) 1937-1945
20. Jensen C.C., Cnop M., Hull R.L., Fujimoto W.Y., and Kahn S.E. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 51 (2002) 2170-2178